161 related articles for article (PubMed ID: 37741694)
1. Chemobrain: An accelerated aging process linking adenosine A
Oliveros A; Poleschuk M; Cole PD; Boison D; Jang MH
Int Rev Neurobiol; 2023; 170():267-305. PubMed ID: 37741694
[TBL] [Abstract][Full Text] [Related]
2. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A
Oliveros A; Yoo KH; Rashid MA; Corujo-Ramirez A; Hur B; Sung J; Liu Y; Hawse JR; Choi DS; Boison D; Jang MH
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2206415119. PubMed ID: 35867768
[TBL] [Abstract][Full Text] [Related]
4. The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain".
Gaman AM; Uzoni A; Popa-Wagner A; Andrei A; Petcu EB
Aging Dis; 2016 May; 7(3):307-17. PubMed ID: 27330845
[TBL] [Abstract][Full Text] [Related]
5. Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real.
Argyriou AA; Assimakopoulos K; Iconomou G; Giannakopoulou F; Kalofonos HP
J Pain Symptom Manage; 2011 Jan; 41(1):126-39. PubMed ID: 20832978
[TBL] [Abstract][Full Text] [Related]
6. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
7. The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function.
Rashid MA; Tang JJ; Yoo KH; Corujo-Ramirez A; Oliveros A; Kim SH; Ullah F; Altawell R; Hawse JR; Cole PD; Jang MH
Front Mol Neurosci; 2023; 16():1295991. PubMed ID: 38095013
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
9. Quantifying chemotherapy-induced cognitive impairment in gastrointestinal cancer patients: A scoping review of methodological concerns in the literature.
Lau J; Khoo AM; Choe L; Hoon A; Tan KK
Asia Pac J Clin Oncol; 2024 May; ():. PubMed ID: 38808735
[TBL] [Abstract][Full Text] [Related]
10. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases.
Nguyen LD; Ehrlich BE
EMBO Mol Med; 2020 Jun; 12(6):e12075. PubMed ID: 32346964
[TBL] [Abstract][Full Text] [Related]
11. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
12. An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI).
Murillo LC; Sutachan JJ; Albarracín SL
Toxicol Rep; 2023; 10():544-553. PubMed ID: 37396847
[TBL] [Abstract][Full Text] [Related]
13. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
14. Animal models of chemotherapy-induced cognitive decline in preclinical drug development.
John J; Kinra M; Mudgal J; Viswanatha GL; Nandakumar K
Psychopharmacology (Berl); 2021 Nov; 238(11):3025-3053. PubMed ID: 34643772
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
16. Effects of chemotherapy for acute lymphoblastic leukemia on cognitive function in animal models of contemporary protocols: A systematic literature review.
Alexander TC; Krull KR
Neurosci Biobehav Rev; 2021 Oct; 129():206-217. PubMed ID: 34352229
[TBL] [Abstract][Full Text] [Related]
17. Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review.
George RP; Semendric I; Hutchinson MR; Whittaker AL
Brain Behav Immun; 2021 May; 94():392-409. PubMed ID: 33516919
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in the elucidation of the mechanisms of chemotherapy-induced cognitive impairment.
Alhowail AH; Aldubayan M
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5807-5817. PubMed ID: 34604972
[TBL] [Abstract][Full Text] [Related]
19. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.
Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843
[TBL] [Abstract][Full Text] [Related]
20. Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.
Orchard TS; Gaudier-Diaz MM; Weinhold KR; Courtney DeVries A
Breast Cancer Res Treat; 2017 Feb; 161(3):391-398. PubMed ID: 27933449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
